Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Regenerex Pharma (RGPX) Short-Term Debt repayments (2012 - 2024)

Regenerex Pharma (RGPX) reported Short-Term Debt repayments of -$8000.0 for Q1 2024, down 222.01% on a QoQ basis from $6557.0 in Q4 2014.

Regenerex Pharma (RGPX) has 3 years of Short-Term Debt repayments data on file, last reported at -$8000.0 in Q1 2024.

  • Quarterly Short-Term Debt repayments changed N/A year-over-year to -$8000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $8057.0 (down 66.51% YoY) and the FY2025 annual result came in at -$113628.0, down 139.22% from the prior year.
  • Short-Term Debt repayments retreated to -$8000.0 in Q1 2024 per RGPX's latest filing, from $6557.0 in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at -$8000.0 in Q1 2024 and bottomed at -$8000.0 in Q1 2024.

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 -8,000.00
Mar 31, 2024 -8,000.00
Nov 30, 2014 6,557.00
Nov 30, 2014 6,557.00
Aug 31, 2014 9,500.00
Aug 31, 2014 9,500.00
May 31, 2014 8,000.00
May 31, 2014 8,000.00
Aug 31, 2012 25,336.00
Aug 31, 2012 25,336.00